US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Related articles
Microsoft's AI chatbot will remember everything you do on a PC
REDMOND, Wash. (AP) — Microsoft wants laptop users to get so comfortable with its artificial intelli2024-05-22House fire kills 4, injures 1 in east China
Four people were killed and one injured after a house caught fire in Xiamen City, east China's F2024-05-22Neymar to return to Santos in 2025: reports
Neymar could leave Al-Hilal to return to his original club Santos next year, according to media repo2024-05-22EU tightens visa requirements for Ethiopians over a lack of government cooperation on deportations
BRUSSELS (AP) — The European Union announced on Monday that it is tightening visa requirements for p2024-05-22Russian general who criticized equipment shortages in Ukraine is arrested on bribery charges
TALLINN, Estonia (AP) — A Russian general who was relieved of duty last year after complaining about2024-05-22David Malukas dropped by McLaren after injured IndyCar driver misses 4th race following bike crash
David Malukas was released by Arrow McLaren on Monday without running an IndyCar race for the team b2024-05-22
atest comment